Pfizer Lyrica Citizen Petition Against Generics Argues Drug Impurities Should Have Ceiling, Not Floor
12:06 EDT 4 Jun 2012 | Elsevier Business Intelligence
Lupin, Actavis and Wockhardt’s novel attempt to establish a “not less than” level for an impurity in their generic pregabalin as a tactic in patent litigation should be rejected, Pfizer argues.
Original Article: Pfizer Lyrica Citizen Petition Against Generics Argues Drug Impurities Should Have Ceiling, Not Floor
More From BioPortfolio on "Pfizer Lyrica Citizen Petition Against Generics Argues Drug Impurities Should Have Ceiling, Not Floor"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
